Rena Yadlapati
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rena Yadlapati has a total of 483 co-authors. Here are the top co-authors by number of shared publications:
John E. Pandolfino
Carlow University, Department of Speech-Language Pathology, Pittsburgh, Pennsylvania, USA
37 shared publications- Chandra Prakash Gyawali
Division of Gastroenterology, Washington University School of Medicine, St. Louis, MO, USA
16 shared publications Madeline Greytak
Department of Gastroenterology and Hepatology University of California San Diego San Diego California USA
14 shared publications- Eric Edison Low
Division of Gastroenterology University of California, San Diego San Diego California USA
12 shared publications - Sabine Roman
Digestive Physiology Hospices Civils de Lyon, Hopital E Herriot Lyon France
12 shared publications - John E. Pandolfino
Division of Gastroenterology and Hepatology, Department of Medicine, Digestive Health Institute, Kenneth C. Griffin Esophageal Center, Northwestern University, Chicago, IL, USA
10 shared publications
Latest Publications
- 12 November 2026
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
The role of high-resolution manometry in the assessment of altered foregut anatomy: scoping review and interpretation recommendations
Introduction: The Chicago Classification provides high-resolution manometry (HRM) criteria for the diagnosis of primary esophageal motility disorders but does not address HRM findings in patients with altered foregut anatomy or post-surgical states. Material and methods: We performed a scoping review of three databases to identify studies reporting HRM findings in altered foregut anatomy, including anti-reflux and bariatric surgery, treated achalasia, head and neck surgery, and rarer conditions such as esophageal diverticula and esophageal atresia. The aim was to synthesize available evidence and provide pragmatic recommendations for HRM interpretation in these conditions not addressed by the Chicago Classification. Results: We identified 168 articles addressing esophageal dysmotility associated with altered foregut anatomy or post-interventional states. Obesity, esophageal diverticula and esophageal strictures can all result in physiological changes in HRM metrics. HRM assesses motor function in hiatus hernia and identifies post-fundoplication outflow obstruction (PFOO) or junctional disruption. Bariatric procedures substantially alter esophagogastric junction anatomy, resulting in hypocontractile or obstructive manometric patterns. Unsuccessfully treated achalasia is defined by elevated IRP and obstruction on provocative maneuvers; the terms adequately treated achalasia (ATA) and treated achalasia with outflow obstruction (TAOO) have been proposed. Pseudo-achalasia is manometrically indistinguishable from primary achalasia. Other conditions including radiation therapy, head and neck surgery and treated esophageal atresia can result in heterogenous and often non-specific HRM findings. Conclusions: The Chicago Classification cannot be applied to motility patterns observed in patients with altered foregut anatomy or following foregut surgery. Instead, HRM interpretation in these settings should integrate anatomic information and focus on clinically actionable findings, particularly obstructive states.
- 12 November 2026
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
The role of high-resolution manometry in the assessment of altered foregut anatomy: scoping review and interpretation recommendations
Introduction: The Chicago Classification provides high-resolution manometry (HRM) criteria for the diagnosis of primary esophageal motility disorders but does not address HRM findings in patients with altered foregut anatomy or post-surgical states. Material and methods: We performed a scoping review of three databases to identify studies reporting HRM findings in altered foregut anatomy, including anti-reflux and bariatric surgery, treated achalasia, head and neck surgery, and rarer conditions such as esophageal diverticula and esophageal atresia. The aim was to synthesize available evidence and provide pragmatic recommendations for HRM interpretation in these conditions not addressed by the Chicago Classification. Results: We identified 168 articles addressing esophageal dysmotility associated with altered foregut anatomy or post-interventional states. Obesity, esophageal diverticula and esophageal strictures can all result in physiological changes in HRM metrics. HRM assesses motor function in hiatus hernia and identifies post-fundoplication outflow obstruction (PFOO) or junctional disruption. Bariatric procedures substantially alter esophagogastric junction anatomy, resulting in hypocontractile or obstructive manometric patterns. Unsuccessfully treated achalasia is defined by elevated IRP and obstruction on provocative maneuvers; the terms adequately treated achalasia (ATA) and treated achalasia with outflow obstruction (TAOO) have been proposed. Pseudo-achalasia is manometrically indistinguishable from primary achalasia. Other conditions including radiation therapy, head and neck surgery and treated esophageal atresia can result in heterogenous and often non-specific HRM findings. Conclusions: The Chicago Classification cannot be applied to motility patterns observed in patients with altered foregut anatomy or following foregut surgery. Instead, HRM interpretation in these settings should integrate anatomic information and focus on clinically actionable findings, particularly obstructive states.
- Open Access
- 2 October 2026
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 38 (10)
Diagnostic Accuracy of High‐Resolution Manometry for Assessing Fundoplication Integrity: Validation of the Padova Classification
Background: Recurrent symptoms after laparoscopic fundoplication (LF) are not fully understood, with ongoing research focusing on their mechanisms. This study aimed to validate the Padova Classification, a postoperative high‐resolution manometry (HRM) framework to distinguish functioning from defective fundoplications. Methods: Prospectively collected data from consecutive patients who underwent post‐LF HRM (2010–2025) were analyzed and categorized as functioning and effective LF (FELF), post‐fundoplication outflow obstruction (PFOO), and ineffective neo‐barrier (INB). Primary analysis involved between‐group comparisons. Padova Classification diagnostic accuracy was evaluated against a composite reference standard (clinical, radiological, endoscopic, and pH‐monitoring criteria) by calculating sensitivity, specificity, positive predictive value, and negative predictive value for each diagnostic category. Diagnostic performance of postoperative integrated relaxation pressure (IRP) for identifying PFOO was evaluated using receiver operating characteristic curve analysis. Key Results: Among 373 patients (42.4% female; median age 54 years, median BMI 25.9 kg/m 2 ; 55.2% Nissen, 44.8% Toupet), FELF, INB, and PFOO were observed in 58.7%, 21.4%, and 18.0% of patients, respectively, with PFOO most frequently seen with Nissen fundoplication ( p = 0.001). The Padova Classification showed sensitivity/specificity 94.7%/97.1% for FELF, 88.8%/96.9% for INB, and 100%/97.4% for PFOO. Postoperative integrated relaxation pressure accurately discriminated PFOO (AUC 0.959–0.984; cutoff 18.1 mmHg; sensitivity 97.7%–98.0%, specificity 93.2%–96.8%), with no difference between ROC curves derived from Padova Classification and reference standard ( p = 0.12). Conclusions: This study confirms that the Padova Classification demonstrates strong performance in assessing postoperative LF function.
- 2 October 2026
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 38 (10)
Open AccessDiagnostic Accuracy of High‐Resolution Manometry for Assessing Fundoplication Integrity: Validation of the Padova Classification
Background: Recurrent symptoms after laparoscopic fundoplication (LF) are not fully understood, with ongoing research focusing on their mechanisms. This study aimed to validate the Padova Classification, a postoperative high‐resolution manometry (HRM) framework to distinguish functioning from defective fundoplications. Methods: Prospectively collected data from consecutive patients who underwent post‐LF HRM (2010–2025) were analyzed and categorized as functioning and effective LF (FELF), post‐fundoplication outflow obstruction (PFOO), and ineffective neo‐barrier (INB). Primary analysis involved between‐group comparisons. Padova Classification diagnostic accuracy was evaluated against a composite reference standard (clinical, radiological, endoscopic, and pH‐monitoring criteria) by calculating sensitivity, specificity, positive predictive value, and negative predictive value for each diagnostic category. Diagnostic performance of postoperative integrated relaxation pressure (IRP) for identifying PFOO was evaluated using receiver operating characteristic curve analysis. Key Results: Among 373 patients (42.4% female; median age 54 years, median BMI 25.9 kg/m 2 ; 55.2% Nissen, 44.8% Toupet), FELF, INB, and PFOO were observed in 58.7%, 21.4%, and 18.0% of patients, respectively, with PFOO most frequently seen with Nissen fundoplication ( p = 0.001). The Padova Classification showed sensitivity/specificity 94.7%/97.1% for FELF, 88.8%/96.9% for INB, and 100%/97.4% for PFOO. Postoperative integrated relaxation pressure accurately discriminated PFOO (AUC 0.959–0.984; cutoff 18.1 mmHg; sensitivity 97.7%–98.0%, specificity 93.2%–96.8%), with no difference between ROC curves derived from Padova Classification and reference standard ( p = 0.12). Conclusions: This study confirms that the Padova Classification demonstrates strong performance in assessing postoperative LF function.
- 18 September 2026
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
Isolated Laryngopharyngeal Symptoms Do Not Predict Objective Reflux Evidence: An International Multicenter Validation Study of the San Diego Consensus Pathway for Selective Upfront Testing
BACKGROUND: Laryngopharyngeal symptoms (LPS) refer to upper aerodigestive tract symptoms with etiologic potential for reflux pathophysiology. We aimed to characterize the clinical presentation/evaluation of LPS and identify predictors of laryngopharyngeal reflux disease (LPRD) in an international cohort of patients with LPS. METHODS: We included adult patients with LPS presenting for esophageal testing at 5 international tertiary centers in 3 world regions. Demographics, clinical symptoms, validated patient-reported outcome instruments and esophageal testing data were obtained. The diagnostic yield of objective gastroesophageal reflux disease (GERD) evidence was compared across LPS presentations. Univariate and multivariable analyses were performed, reported as odds ratios (OR) and 95% confidence intervals (CI). RESULTS: Of 408 patients (age 53.3 ± 0.7 years, 70% women), 135 (33.1%) had isolated LPS and 273 (66.9%) had LPS with typical reflux symptoms. Symptom burden was higher in LPS with typical symptoms ( P ≤ 0.004), as was objective GERD evidence (29.7% vs 17.0%, P = 0.006), with similar diagnostic yields between wireless and pH-impedance monitoring in both isolated LPS and LPS with typical symptoms ( P = 0.36). On multivariable logistic regression evaluating predictors for conclusive GERD, typical symptoms (OR 2.71, CI 1.33–5.55, P = 0.006), hiatus hernia (OR 1.80, CI 1.24–2.62, P = 0.002) and body mass index (OR 1.08, CI 1.03–1.14, P = 0.002) and were independent predictors for conclusive GERD, but LPS type and severity did not predict LPRD. Across world regions, symptom burden was higher despite lower GERD evidence in Asian patients. DISCUSSION: Clinical presentation of isolated LPS is not predictive of LPRD, unlike LPS with typical symptoms. Our findings support the San Diego Consensus recommendations for selective up-front testing in isolated LPS.
- 18 September 2026
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
Isolated Laryngopharyngeal Symptoms Do Not Predict Objective Reflux Evidence: An International Multicenter Validation Study of the San Diego Consensus Pathway for Selective Upfront Testing
BACKGROUND: Laryngopharyngeal symptoms (LPS) refer to upper aerodigestive tract symptoms with etiologic potential for reflux pathophysiology. We aimed to characterize the clinical presentation/evaluation of LPS and identify predictors of laryngopharyngeal reflux disease (LPRD) in an international cohort of patients with LPS. METHODS: We included adult patients with LPS presenting for esophageal testing at 5 international tertiary centers in 3 world regions. Demographics, clinical symptoms, validated patient-reported outcome instruments and esophageal testing data were obtained. The diagnostic yield of objective gastroesophageal reflux disease (GERD) evidence was compared across LPS presentations. Univariate and multivariable analyses were performed, reported as odds ratios (OR) and 95% confidence intervals (CI). RESULTS: Of 408 patients (age 53.3 ± 0.7 years, 70% women), 135 (33.1%) had isolated LPS and 273 (66.9%) had LPS with typical reflux symptoms. Symptom burden was higher in LPS with typical symptoms ( P ≤ 0.004), as was objective GERD evidence (29.7% vs 17.0%, P = 0.006), with similar diagnostic yields between wireless and pH-impedance monitoring in both isolated LPS and LPS with typical symptoms ( P = 0.36). On multivariable logistic regression evaluating predictors for conclusive GERD, typical symptoms (OR 2.71, CI 1.33–5.55, P = 0.006), hiatus hernia (OR 1.80, CI 1.24–2.62, P = 0.002) and body mass index (OR 1.08, CI 1.03–1.14, P = 0.002) and were independent predictors for conclusive GERD, but LPS type and severity did not predict LPRD. Across world regions, symptom burden was higher despite lower GERD evidence in Asian patients. DISCUSSION: Clinical presentation of isolated LPS is not predictive of LPRD, unlike LPS with typical symptoms. Our findings support the San Diego Consensus recommendations for selective up-front testing in isolated LPS.
- 2 September 2026
- Published by Elsevier in Clinical Gastroenterology and Hepatology
Reply
- 1 May 2026
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 24 (8) , 2069-2072
Schatzki’s Rings: Recognition, Significance, and Management
- 1 May 2026
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 24 (8) , 2069-2072
Schatzki’s Rings: Recognition, Significance, and Management
- Open Access
- 23 December 2025
- Published by Sociedad Argentina de Gastroenterologia in Acta gastroenterológica latinoamericana
- Vol. 55 (4) , 292-302
Laryngopharyngeal Reflux: Historical Perspectives, Current Diagnostics and Therapies, and Remaining Challenges
The concept of laryngopharyngeal reflux has evolved since it was first used to describe the retrograde flow of gastric contents into the upper airway leading to upper airway symptoms; decades of cross-disciplinary research have led to our current understanding of this process, which emphasizes differentiating laryngopharyngeal reflux disease (characterized by symptoms with objective evidence of reflux) from laryngopharyngeal symptoms (which can occur with or without pathological reflux). It is essential to recognize this distinction for effective management because laryngopharyngeal reflux disease may respond to anti-reflux therapy, whereas the management of laryngopharyngeal symptoms depends on the clinical entity or entities contributing to them. This review summarizes the historical development of the laryngopharyngeal reflux concept, outlines current diagnostic and therapeutic approaches for laryngopharyngeal reflux disease, and highlights ongoing challenges and opportunities for future research, concluding that continued interdisciplinary collaboration is essential for improving both evidence-based diagnoses and effective treatment outcomes.
- 23 December 2025
- Published by Sociedad Argentina de Gastroenterologia in Acta gastroenterológica latinoamericana
- Vol. 55 (4) , 292-302
Open AccessLaryngopharyngeal Reflux: Historical Perspectives, Current Diagnostics and Therapies, and Remaining Challenges
The concept of laryngopharyngeal reflux has evolved since it was first used to describe the retrograde flow of gastric contents into the upper airway leading to upper airway symptoms; decades of cross-disciplinary research have led to our current understanding of this process, which emphasizes differentiating laryngopharyngeal reflux disease (characterized by symptoms with objective evidence of reflux) from laryngopharyngeal symptoms (which can occur with or without pathological reflux). It is essential to recognize this distinction for effective management because laryngopharyngeal reflux disease may respond to anti-reflux therapy, whereas the management of laryngopharyngeal symptoms depends on the clinical entity or entities contributing to them. This review summarizes the historical development of the laryngopharyngeal reflux concept, outlines current diagnostic and therapeutic approaches for laryngopharyngeal reflux disease, and highlights ongoing challenges and opportunities for future research, concluding that continued interdisciplinary collaboration is essential for improving both evidence-based diagnoses and effective treatment outcomes.
- Open Access
- 23 December 2025
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 24 (8) , 2108-2117
Randomized Controlled Trial of Upper Esophageal Sphincter Assist Device in Laryngopharyngeal Reflux Disease
- 23 December 2025
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 24 (8) , 2108-2117
Open AccessRandomized Controlled Trial of Upper Esophageal Sphincter Assist Device in Laryngopharyngeal Reflux Disease
- Open Access
- 3 November 2025
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 37 (12) , e70196
Validation of Padova Classification of Post‐Fundoplication Outflow Obstruction on High‐Resolution Manometry in an International Multi‐Center Study
Background: Dysphagia after laparoscopic Nissen fundoplication (LNF) is common and may be due to post‐fundoplication outflow obstruction (PFOO) as defined by high‐resolution manometry (HRM) using the Padova Classification. This study aimed to compare clinical and HRM parameters between patients with manometric PFOO and those with a functioning, effective fundoplication (FELF), and to evaluate treatment outcomes in PFOO patients. Methods: This retrospective study from two international centers included patients who underwent LNF and postoperative HRM between January 2000 and January 2025. Patients were categorized into PFOO (manometric PFOO) and FELF (manometric FELF and normal reflux study) groups. HRM parameters including LES basal pressure, integrated relaxation pressure (IRP), and esophageal body function were compared. Postoperative dysphagia was assessed clinically, and treatment outcomes in PFOO patients were evaluated. Results: Among 106 patients (62 PFOO, 44 FELF), the PFOO group showed significantly higher median LES basal pressure (41.2 vs. 23.7 mmHg, p < 0.01), IRP (19.3 vs. 10.3 mmHg, p < 0.01), and LES lengths ( p = 0.01). PFOO patients had an increased incidence of elevated intrabolus pressure and premature swallows ( p < 0.01). Dysphagia was reported in 89% of PFOO patients versus 5% in FELF ( p < 0.01). Of symptomatic PFOO patients undergoing retreatment (pneumatic dilation, redo surgery, or both), 89% achieved symptom improvement. Conclusions: This first study applying the Padova Classification confirms HRM can distinguish obstructive from functional fundoplications post‐LNF, supporting its diagnostic role in managing postoperative dysphagia.
- 3 November 2025
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 37 (12) , e70196
Open AccessValidation of Padova Classification of Post‐Fundoplication Outflow Obstruction on High‐Resolution Manometry in an International Multi‐Center Study
Background: Dysphagia after laparoscopic Nissen fundoplication (LNF) is common and may be due to post‐fundoplication outflow obstruction (PFOO) as defined by high‐resolution manometry (HRM) using the Padova Classification. This study aimed to compare clinical and HRM parameters between patients with manometric PFOO and those with a functioning, effective fundoplication (FELF), and to evaluate treatment outcomes in PFOO patients. Methods: This retrospective study from two international centers included patients who underwent LNF and postoperative HRM between January 2000 and January 2025. Patients were categorized into PFOO (manometric PFOO) and FELF (manometric FELF and normal reflux study) groups. HRM parameters including LES basal pressure, integrated relaxation pressure (IRP), and esophageal body function were compared. Postoperative dysphagia was assessed clinically, and treatment outcomes in PFOO patients were evaluated. Results: Among 106 patients (62 PFOO, 44 FELF), the PFOO group showed significantly higher median LES basal pressure (41.2 vs. 23.7 mmHg, p < 0.01), IRP (19.3 vs. 10.3 mmHg, p < 0.01), and LES lengths ( p = 0.01). PFOO patients had an increased incidence of elevated intrabolus pressure and premature swallows ( p < 0.01). Dysphagia was reported in 89% of PFOO patients versus 5% in FELF ( p < 0.01). Of symptomatic PFOO patients undergoing retreatment (pneumatic dilation, redo surgery, or both), 89% achieved symptom improvement. Conclusions: This first study applying the Padova Classification confirms HRM can distinguish obstructive from functional fundoplications post‐LNF, supporting its diagnostic role in managing postoperative dysphagia.
- Open Access
- 13 October 2025
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 121 (8) , 1866-1874
Vonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Nonerosive Reflux Disease
INTRODUCTION: This analysis of a phase 3 randomized trial evaluated the efficacy of vonoprazan on prespecified end points for nighttime symptoms in patients with nonerosive reflux disease. METHODS: Adults with heartburn ≥4 d/wk and without erosive esophagitis were randomized to placebo, vonoprazan 10 mg, or vonoprazan 20 mg. After 4 weeks, subjects on placebo were rerandomized to vonoprazan 10 or 20 mg, and those already on vonoprazan continued the same dose for an additional 20 weeks. Nocturnal Gastro-esophageal Reflux Disease Symptom Severity and Impact Questionnaire (N-GSSIQ), a validated instrument for nocturnal gastroesophageal reflux disease, was completed at baseline and weeks 4, 12, and 24. Minimal important differences for N-GSSIQ total score and subscales were defined as ≥0.4. RESULTS: Among 772 subjects, the mean percentage of heartburn-free nights at week 4 was 43.3% for placebo vs 59.9% for vonoprazan 10 mg (least squares [LS] mean difference = 16.5%, P < 0.0001) and 56.4% for vonoprazan 20 mg (LS mean difference, 13.1%, P < 0.0001). Vonoprazan improved N-GSSIQ total score (LS mean difference vs placebo of −2.9 and −1.8 for vonoprazan 10 and 20 mg, respectively; P < 0.005 for both comparisons), nocturnal symptom severity subscale (LS mean difference vs placebo of −5.4 and −3.5 for vonoprazan 10 and 20 mg; P < 0.001 for both comparisons), and concern about nocturnal gastroesophageal reflux disease subscale (LS mean difference vs placebo of −2.0 for both vonoprazan 10 and 20 mg; P < 0.0001). The benefit on heartburn-free nights and N-GSSIQ scores was observed through the additional 20 weeks. DISCUSSION: Our study suggests that vonoprazan leads to relief of nighttime heartburn in patients with heartburn and a normal endoscopy.
- 13 October 2025
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 121 (8) , 1866-1874
Open AccessVonoprazan Improves Nocturnal Gastroesophageal Reflux Symptoms in Nonerosive Reflux Disease
INTRODUCTION: This analysis of a phase 3 randomized trial evaluated the efficacy of vonoprazan on prespecified end points for nighttime symptoms in patients with nonerosive reflux disease. METHODS: Adults with heartburn ≥4 d/wk and without erosive esophagitis were randomized to placebo, vonoprazan 10 mg, or vonoprazan 20 mg. After 4 weeks, subjects on placebo were rerandomized to vonoprazan 10 or 20 mg, and those already on vonoprazan continued the same dose for an additional 20 weeks. Nocturnal Gastro-esophageal Reflux Disease Symptom Severity and Impact Questionnaire (N-GSSIQ), a validated instrument for nocturnal gastroesophageal reflux disease, was completed at baseline and weeks 4, 12, and 24. Minimal important differences for N-GSSIQ total score and subscales were defined as ≥0.4. RESULTS: Among 772 subjects, the mean percentage of heartburn-free nights at week 4 was 43.3% for placebo vs 59.9% for vonoprazan 10 mg (least squares [LS] mean difference = 16.5%, P < 0.0001) and 56.4% for vonoprazan 20 mg (LS mean difference, 13.1%, P < 0.0001). Vonoprazan improved N-GSSIQ total score (LS mean difference vs placebo of −2.9 and −1.8 for vonoprazan 10 and 20 mg, respectively; P < 0.005 for both comparisons), nocturnal symptom severity subscale (LS mean difference vs placebo of −5.4 and −3.5 for vonoprazan 10 and 20 mg; P < 0.001 for both comparisons), and concern about nocturnal gastroesophageal reflux disease subscale (LS mean difference vs placebo of −2.0 for both vonoprazan 10 and 20 mg; P < 0.0001). The benefit on heartburn-free nights and N-GSSIQ scores was observed through the additional 20 weeks. DISCUSSION: Our study suggests that vonoprazan leads to relief of nighttime heartburn in patients with heartburn and a normal endoscopy.